Literature DB >> 24578499

Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity?

Mladen V Tzvetkov1, Tina Seitz, Kristin Bokelmann, Thomas Mueller, Jürgen Brockmöller, Hermann Koepsell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24578499     DOI： 10.1182/blood-2013-11-535864

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  OCT1 and imatinib transport in CML: is it clinically relevant?

Authors:  D B Watkins; T P Hughes; D L White
Journal:  Leukemia       Date:  2015-07-09       Impact factor: 11.528

2.  MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients.

Authors:  S Harrach; C Schmidt-Lauber; T Pap; H Pavenstädt; E Schlatter; E Schmidt; W E Berdel; U Schulze; B Edemir; S Jeromin; T Haferlach; G Ciarimboli; J Bertrand
Journal:  Blood Cancer J       Date:  2016-09-16       Impact factor: 11.037

Review 3.  Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia.

Authors:  Marialuisa Polillo; Sara Galimberti; Claudia Baratè; Mario Petrini; Romano Danesi; Antonello Di Paolo
Journal:  Int J Mol Sci       Date:  2015-09-21       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.